Immunisation against tick-bone encephalitis by widely used vaccines: Short-term history and current recommendations [3]

Clinical Microbiology and Infection

Volumn 11, Issue 5, 2005, Pages 424-426

  Beran, Jiri ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

FSME IMMUN; FSME IMMUN JUNIOR; HUMAN SERUM ALBUMIN; INACTIVATED VACCINE; POLYGELINE; THIOMERSAL; TICK BORNE ENCEPHALITIS VACCINE; TICOVAC; VIRUS VACCINE;

DRUG APPROVAL; DRUG FORMULATION; HUMAN; IMMUNIZATION; IXODES PERSULCATUS; IXODES RICINUS; LETTER; PRIORITY JOURNAL; TICK; TICK BORNE ENCEPHALITIS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VIRUS TRANSMISSION; COMPARATIVE STUDY; IMMUNOLOGY; NOTE; VACCINATION;

ENCEPHALITIS, TICK-BORNE; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; VACCINATION; VIRAL VACCINES;

EID: 17744370741     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01115.x     Document Type: Letter

References (12)

1. Rendi-Wagner P. Risk and prevention of tick-borne encephalitis in travelers. J Travel Med 2004; 11: 307-312.
2. Charrel RN, Attoui H, Butenko AM et al. Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect 2004; 10: 1040-1055.
3. Ehrlich HJ, Pavlova BG, Fritsch S et al. Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity. Vaccine 2003; 22: 217-223.
4. Pavlova BG, Loew-Baselli A, Fritsch S et al. Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN 'NEW' in children: results of post-marketing surveillance. Vaccine 2003; 21: 742-745.
5. Zent O, Hennig R. Post-marketing surveillance of immediate allergic reactions: polygeline-based versus polygeline-free pediatric TBE vaccine. Vaccine 2004; 23: 579-584.
6. Zent O, Schwarz TF, Plentz A et al. TBE booster immunization in adults - first experience with a new tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer. Int J Med Microbiol 2004; 293(suppl 37): 134-138.
7. Beran J, Douda P, Gniel D et al. Long-term immunity after vaccination against tick-borne encephalitis with Encepur using the rapid vaccination schedule. Int J Med Microbiol 2004; 293 suppl 37): 130-133.
8. Zent O, Plentz A, Schwarz TF et al. TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary? Vaccine 2004; 23: 312-315.
9. Anonymous. Impfplan 2005 Österreich. Empfehlungen des Obersten Sanitätsrates (Impfausschuss) vom 9. November 2004. http://www.bmgf.gv.at.
10. Löw-Baselli A, Pöllabauer EM, Fritsch S et al. FSME-IMMUN - new clinical data on rapid immunization. Ellipse 2004; 20: 32-33.
11. Rendi-Wagner P, Kundi M, Zent O et al. Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation. Vaccine 2004; 23 427-434.
12. Rendi-Wagner P, Kundi M, Zent O et al. Persistence of protective immunity following vaccination against tickborne encephalitis - longer than expected? Vaccine 2004; 22: 2743-2749.